AKZO NOBEL SPONS.ADRS 1/3 (AKUP) — Capital Reinvestment Ratio
Latest as of December 2025:
0.22x
AKZO NOBEL SPONS.ADRS 1/3 (AKUP) has a Capital Reinvestment Ratio of 0.22x as of December 2025, meaning it reinvests 0% of its operating cash flow (€462.00 Million) in capital expenditures (€100.00 Million). See AKUP cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.22x
Capex / Operating Cash Flow
Operating Cash Flow
€462.00 Million
EUR
Capital Expenditures
€100.00 Million
EUR
Data as of
Dec 2025
Most recent filing
AKZO NOBEL SPONS.ADRS 1/3 Capital Reinvestment Ratio (2022–2025)
This chart tracks AKZO NOBEL SPONS.ADRS 1/3's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for AKZO NOBEL SPONS.ADRS 1/3 (2022–2025)
Year-by-year Capital Reinvestment Ratio for AKZO NOBEL SPONS.ADRS 1/3 from 2022 to 2025. For live market cap and broader valuation context, see market cap of AKZO NOBEL SPONS.ADRS 1/3.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | €915.00 Million | €309.00 Million | ▼ -25.7% |
| 2024 | 0.45x | €673.00 Million | €306.00 Million | ▲ +79.0% |
| 2023 | 0.25x | €1.13 Billion | €286.00 Million | ▼ -77.1% |
| 2022 | 1.11x | €263.00 Million | €292.00 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow